Literature DB >> 28099827

Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129.

Tzehow Mok1, Zane Jaunmuktane2, Susan Joiner1, Tracy Campbell1, Catherine Morgan3, Benjamin Wakerley3, Farhad Golestani3, Peter Rudge4, Simon Mead4, H Rolf Jäger4, Jonathan D F Wadsworth4, Sebastian Brandner4, John Collinge4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28099827     DOI： 10.1056/NEJMc1610003

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  37 in total

1.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

2.  Novel diagnostic technologies for clinical and frontline use: Advanced diagnostics based on molecular markers and analysis technologies has been improving diagnosis across a wide range of diseases.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2017-05-17       Impact factor: 8.807

3.  Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.

Authors:  Roberta Galeno; Michele Angelo Di Bari; Romolo Nonno; Franco Cardone; Marco Sbriccoli; Silvia Graziano; Loredana Ingrosso; Michele Fiorini; Angelina Valanzano; Giulia Pasini; Anna Poleggi; Ramona Vinci; Anna Ladogana; Maria Puopolo; Salvatore Monaco; Umberto Agrimi; Gianluigi Zanusso; Maurizio Pocchiari
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

4.  Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrPSc and Targeting PrPSc for Lysosomal Degradation.

Authors:  Joanna E Pankiewicz; Sandrine Sanchez; Kent Kirshenbaum; Regina B Kascsak; Richard J Kascsak; Martin J Sadowski
Journal:  Mol Neurobiol       Date:  2018-07-09       Impact factor: 5.590

5.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

6.  Unexpected prion phenotypes in experimentally transfused animals: predictive models for humans?

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Prion       Date:  2018-08-16       Impact factor: 3.931

Review 7.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

8.  Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Nina Jaffré; Vincent Lebon; Etienne Levavasseur; Nathalie Streichenberger; Chryslain Sumian; Armand Perret-Liaudet; Marc Eloit; Olivier Andreoletti; Stéphane Haïk; Philippe Hantraye; Jean-Philippe Deslys
Journal:  Nat Commun       Date:  2017-11-02       Impact factor: 14.919

9.  Met166 -Glu168 residues in human PrP β2-α2 loop account for evolutionary resistance to prion infection.

Authors:  Juan Carlos Espinosa; Alba Marín-Moreno; Patricia Aguilar-Calvo; Juan María Torres
Journal:  Neuropathol Appl Neurobiol       Date:  2020-12-22       Impact factor: 8.090

10.  What's next for genomics and prion diseases?

Authors:  Stephanie A Booth
Journal:  Future Sci OA       Date:  2017-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.